SEGMENT INFORMATION (Details) - USD ($)
|
3 Months Ended |
9 Months Ended |
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
| REVENUE |
$ 47,917
|
$ 2,543,823
|
$ 146,915
|
$ 6,941,151
|
| COST OF REVENUE (Including $nil and $7,233 of cost of revenue from related parties for the three-month period ended September 30, 2026 and 2025, respectively, and $nil and $9,404 of cost of revenue from related parties for the nine-month period ended September 30, 2026 and 2025, respectively) |
(43,429)
|
(2,166,138)
|
(130,235)
|
(5,851,951)
|
| GROSS PROFIT |
4,488
|
377,685
|
16,680
|
1,089,200
|
| Interest income |
16,541
|
20,778
|
54,903
|
74,114
|
| Other income |
6,239
|
40,414
|
22,779
|
147,231
|
| Sales and marketing |
(35,007)
|
(551,569)
|
(123,762)
|
(1,700,691)
|
| Research and development |
(13,578)
|
(14,876)
|
(41,736)
|
(39,572)
|
| Fair value loss on investments in equity securities |
|
|
0
|
(91,243)
|
| Share-based compensation |
799,998
|
0
|
799,998
|
0
|
| TOTAL OPERATING EXPENSES |
(1,084,249)
|
(1,191,054)
|
(1,985,252)
|
(3,344,869)
|
| (LOSS)/PROFIT FROM OPERATIONS |
(1,052,579)
|
(705,609)
|
(1,880,825)
|
(1,941,940)
|
| FINANCE COSTS |
(1,801)
|
(3,382)
|
(3,581)
|
(6,550)
|
| Loss before income taxes, amount |
(1,054,380)
|
(708,991)
|
(1,884,406)
|
(1,948,490)
|
| Tax expense |
0
|
0
|
0
|
0
|
| Fair value loss on investments in equity securities |
|
|
0
|
91,243
|
| Share-based compensation |
$ (799,998)
|
$ 0
|
(799,998)
|
0
|
| Trading Of Industrial Chemicals [Member] |
|
|
|
|
| REVENUE |
|
|
144,954
|
6,929,849
|
| COST OF REVENUE (Including $nil and $7,233 of cost of revenue from related parties for the three-month period ended September 30, 2026 and 2025, respectively, and $nil and $9,404 of cost of revenue from related parties for the nine-month period ended September 30, 2026 and 2025, respectively) |
|
|
(128,985)
|
(5,846,956)
|
| GROSS PROFIT |
|
|
15,969
|
1,082,893
|
| Dividend income |
|
|
|
21,752
|
| Interest income |
|
|
16,630
|
10,468
|
| Gain from foreign exchange |
|
|
1,790
|
|
| Other income |
|
|
22,779
|
136,312
|
| Fair value gain on investments in equity securities |
|
|
|
28,256
|
| Gain on disposal of investments in equity securities |
|
|
|
42,376
|
| TOTAL OTHER INCOME |
|
|
41,199
|
239,164
|
| Sales and marketing |
|
|
(2,790)
|
(1,577,214)
|
| Research and development |
|
|
0
|
0
|
| General and administrative |
|
|
(162,031)
|
(492,464)
|
| Fair value loss on investments in equity securities |
|
|
|
(119,499)
|
| Provision for expected credit losses |
|
|
(76,814)
|
(121,030)
|
| Share-based compensation |
|
|
0
|
|
| TOTAL OPERATING EXPENSES |
|
|
(241,635)
|
(2,310,207)
|
| (LOSS)/PROFIT FROM OPERATIONS |
|
|
(184,467)
|
(988,150)
|
| FINANCE COSTS |
|
|
(1,574)
|
(6,266)
|
| Loss before income taxes, amount |
|
|
(186,041)
|
(994,416)
|
| Tax expense |
|
|
0
|
0
|
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS |
|
|
(186,041)
|
(994,416)
|
| Fair value loss on investments in equity securities |
|
|
|
119,499
|
| Gain on disposal of investments in equity securities |
|
|
|
(42,376)
|
| Share-based compensation |
|
|
0
|
|
| Provision For Genomic Screening Services [Member] |
|
|
|
|
| REVENUE |
|
|
1,961
|
11,302
|
| COST OF REVENUE (Including $nil and $7,233 of cost of revenue from related parties for the three-month period ended September 30, 2026 and 2025, respectively, and $nil and $9,404 of cost of revenue from related parties for the nine-month period ended September 30, 2026 and 2025, respectively) |
|
|
(1,250)
|
(4,995)
|
| GROSS PROFIT |
|
|
711
|
6,307
|
| Dividend income |
|
|
|
0
|
| Interest income |
|
|
38,273
|
63,646
|
| Gain from foreign exchange |
|
|
8,227
|
|
| Other income |
|
|
0
|
10,919
|
| Fair value gain on investments in equity securities |
|
|
|
0
|
| Gain on disposal of investments in equity securities |
|
|
|
0
|
| TOTAL OTHER INCOME |
|
|
46,500
|
74,565
|
| Sales and marketing |
|
|
(98,154)
|
(86,275)
|
| Research and development |
|
|
(41,736)
|
(39,572)
|
| General and administrative |
|
|
(180,877)
|
(270,725)
|
| Fair value loss on investments in equity securities |
|
|
|
0
|
| Provision for expected credit losses |
|
|
0
|
0
|
| Share-based compensation |
|
|
0
|
|
| TOTAL OPERATING EXPENSES |
|
|
(320,767)
|
(396,572)
|
| (LOSS)/PROFIT FROM OPERATIONS |
|
|
(273,556)
|
(315,700)
|
| FINANCE COSTS |
|
|
0
|
(32)
|
| Loss before income taxes, amount |
|
|
(273,556)
|
(315,732)
|
| Tax expense |
|
|
0
|
0
|
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS |
|
|
(273,556)
|
(315,732)
|
| Fair value loss on investments in equity securities |
|
|
|
0
|
| Gain on disposal of investments in equity securities |
|
|
|
0
|
| Share-based compensation |
|
|
0
|
|
| Investment Holding [Member] |
|
|
|
|
| REVENUE |
|
|
0
|
0
|
| COST OF REVENUE (Including $nil and $7,233 of cost of revenue from related parties for the three-month period ended September 30, 2026 and 2025, respectively, and $nil and $9,404 of cost of revenue from related parties for the nine-month period ended September 30, 2026 and 2025, respectively) |
|
|
0
|
0
|
| GROSS PROFIT |
|
|
0
|
0
|
| Dividend income |
|
|
|
0
|
| Interest income |
|
|
0
|
0
|
| Gain from foreign exchange |
|
|
48
|
|
| Other income |
|
|
0
|
0
|
| Fair value gain on investments in equity securities |
|
|
|
0
|
| Gain on disposal of investments in equity securities |
|
|
|
0
|
| TOTAL OTHER INCOME |
|
|
48
|
0
|
| Research and development |
|
|
0
|
0
|
| General and administrative |
|
|
(600,034)
|
(600,888)
|
| Fair value loss on investments in equity securities |
|
|
|
0
|
| Provision for expected credit losses |
|
|
0
|
0
|
| Share-based compensation |
|
|
(799,998)
|
|
| TOTAL OPERATING EXPENSES |
|
|
(1,422,850)
|
(638,090)
|
| (LOSS)/PROFIT FROM OPERATIONS |
|
|
(1,422,802)
|
(638,090)
|
| FINANCE COSTS |
|
|
(2,007)
|
(252)
|
| Loss before income taxes, amount |
|
|
(1,424,809)
|
(638,342)
|
| Tax expense |
|
|
0
|
0
|
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS |
|
|
(1,424,809)
|
(638,342)
|
| Fair value loss on investments in equity securities |
|
|
|
0
|
| Gain on disposal of investments in equity securities |
|
|
|
0
|
| Share-based compensation |
|
|
799,998
|
|
| Sales and marketing |
|
|
(22,818)
|
(37,202)
|
| Foreign, Malaysia |
|
|
|
|
| REVENUE |
|
|
146,915
|
6,941,151
|
| COST OF REVENUE (Including $nil and $7,233 of cost of revenue from related parties for the three-month period ended September 30, 2026 and 2025, respectively, and $nil and $9,404 of cost of revenue from related parties for the nine-month period ended September 30, 2026 and 2025, respectively) |
|
|
(130,235)
|
(5,851,951)
|
| GROSS PROFIT |
|
|
16,680
|
1,089,200
|
| Dividend income |
|
|
|
21,752
|
| Interest income |
|
|
54,903
|
74,114
|
| Gain from foreign exchange |
|
|
10,017
|
|
| Other income |
|
|
22,779
|
147,231
|
| Fair value gain on investments in equity securities |
|
|
|
119,499
|
| Gain on disposal of investments in equity securities |
|
|
|
42,376
|
| TOTAL OTHER INCOME |
|
|
87,699
|
313,729
|
| Sales and marketing |
|
|
(100,944)
|
(1,663,489)
|
| Research and development |
|
|
(41,736)
|
(39,572)
|
| General and administrative |
|
|
(342,908)
|
(763,189)
|
| Fair value loss on investments in equity securities |
|
|
|
(28,256)
|
| Provision for expected credit losses |
|
|
(76,814)
|
(121,030)
|
| Share-based compensation |
|
|
0
|
|
| TOTAL OPERATING EXPENSES |
|
|
(562,402)
|
(2,706,779)
|
| (LOSS)/PROFIT FROM OPERATIONS |
|
|
(458,023)
|
(1,303,850)
|
| FINANCE COSTS |
|
|
(1,574)
|
(6,298)
|
| Loss before income taxes, amount |
|
|
(459,597)
|
(1,310,148)
|
| Tax expense |
|
|
0
|
0
|
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS |
|
|
(459,597)
|
(1,310,148)
|
| Fair value loss on investments in equity securities |
|
|
|
28,256
|
| Gain on disposal of investments in equity securities |
|
|
|
(42,376)
|
| Share-based compensation |
|
|
0
|
|
| United States of America |
|
|
|
|
| REVENUE |
|
|
0
|
0
|
| COST OF REVENUE (Including $nil and $7,233 of cost of revenue from related parties for the three-month period ended September 30, 2026 and 2025, respectively, and $nil and $9,404 of cost of revenue from related parties for the nine-month period ended September 30, 2026 and 2025, respectively) |
|
|
0
|
0
|
| GROSS PROFIT |
|
|
0
|
0
|
| Dividend income |
|
|
|
0
|
| Interest income |
|
|
0
|
0
|
| Gain from foreign exchange |
|
|
48
|
|
| Other income |
|
|
0
|
|
| Fair value gain on investments in equity securities |
|
|
|
0
|
| Gain on disposal of investments in equity securities |
|
|
|
0
|
| TOTAL OTHER INCOME |
|
|
48
|
0
|
| Sales and marketing |
|
|
(22,818)
|
(37,202)
|
| Research and development |
|
|
0
|
0
|
| General and administrative |
|
|
(600,034)
|
(600,888)
|
| Fair value loss on investments in equity securities |
|
|
|
0
|
| Provision for expected credit losses |
|
|
0
|
0
|
| Share-based compensation |
|
|
799,998
|
|
| TOTAL OPERATING EXPENSES |
|
|
(1,422,850)
|
(638,090)
|
| (LOSS)/PROFIT FROM OPERATIONS |
|
|
(1,422,802)
|
(638,090)
|
| FINANCE COSTS |
|
|
(2,007)
|
(252)
|
| Loss before income taxes, amount |
|
|
(1,424,809)
|
(638,342)
|
| Tax expense |
|
|
0
|
0
|
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS |
|
|
(1,424,809)
|
(638,342)
|
| Fair value loss on investments in equity securities |
|
|
|
0
|
| Gain on disposal of investments in equity securities |
|
|
|
0
|
| Share-based compensation |
|
|
(799,998)
|
|
| By Business Unit |
|
|
|
|
| REVENUE |
|
|
146,915
|
6,941,151
|
| COST OF REVENUE (Including $nil and $7,233 of cost of revenue from related parties for the three-month period ended September 30, 2026 and 2025, respectively, and $nil and $9,404 of cost of revenue from related parties for the nine-month period ended September 30, 2026 and 2025, respectively) |
|
|
(130,235)
|
(5,851,951)
|
| GROSS PROFIT |
|
|
16,680
|
1,089,200
|
| Dividend income |
|
|
|
21,752
|
| Interest income |
|
|
54,903
|
74,114
|
| Gain from foreign exchange |
|
|
10,065
|
|
| Other income |
|
|
22,779
|
147,231
|
| Fair value gain on investments in equity securities |
|
|
|
28,256
|
| Gain on disposal of investments in equity securities |
|
|
|
42,376
|
| TOTAL OTHER INCOME |
|
|
87,747
|
313,729
|
| Sales and marketing |
|
|
(123,762)
|
(1,700,691)
|
| Research and development |
|
|
(41,736)
|
(39,572)
|
| General and administrative |
|
|
(942,942)
|
(1,364,077)
|
| Fair value loss on investments in equity securities |
|
|
|
(119,499)
|
| Provision for expected credit losses |
|
|
(76,814)
|
(121,030)
|
| Share-based compensation |
|
|
(799,998)
|
|
| TOTAL OPERATING EXPENSES |
|
|
(1,985,252)
|
(3,344,869)
|
| (LOSS)/PROFIT FROM OPERATIONS |
|
|
(1,880,825)
|
(1,941,940)
|
| FINANCE COSTS |
|
|
(3,581)
|
(6,550)
|
| Loss before income taxes, amount |
|
|
(1,884,406)
|
(1,948,490)
|
| Tax expense |
|
|
0
|
0
|
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS |
|
|
(1,884,406)
|
(1,948,490)
|
| Fair value loss on investments in equity securities |
|
|
|
119,499
|
| Gain on disposal of investments in equity securities |
|
|
|
(42,376)
|
| Share-based compensation |
|
|
799,998
|
|
| By Country |
|
|
|
|
| REVENUE |
|
|
146,915
|
6,941,151
|
| COST OF REVENUE (Including $nil and $7,233 of cost of revenue from related parties for the three-month period ended September 30, 2026 and 2025, respectively, and $nil and $9,404 of cost of revenue from related parties for the nine-month period ended September 30, 2026 and 2025, respectively) |
|
|
(130,235)
|
(5,851,951)
|
| GROSS PROFIT |
|
|
16,680
|
1,089,200
|
| Dividend income |
|
|
|
21,752
|
| Interest income |
|
|
54,903
|
74,114
|
| Gain from foreign exchange |
|
|
10,065
|
|
| Other income |
|
|
22,779
|
147,231
|
| Fair value gain on investments in equity securities |
|
|
|
28,256
|
| Gain on disposal of investments in equity securities |
|
|
|
42,376
|
| TOTAL OTHER INCOME |
|
|
87,747
|
313,729
|
| Sales and marketing |
|
|
(123,762)
|
(1,700,691)
|
| Research and development |
|
|
(41,736)
|
(39,572)
|
| General and administrative |
|
|
(942,942)
|
(1,364,077)
|
| Fair value loss on investments in equity securities |
|
|
|
(119,499)
|
| Provision for expected credit losses |
|
|
(76,814)
|
(121,030)
|
| Share-based compensation |
|
|
799,998
|
|
| TOTAL OPERATING EXPENSES |
|
|
(1,985,252)
|
(3,344,869)
|
| (LOSS)/PROFIT FROM OPERATIONS |
|
|
1,880,825
|
(1,941,940)
|
| FINANCE COSTS |
|
|
(3,581)
|
(6,550)
|
| Loss before income taxes, amount |
|
|
(1,884,406)
|
(1,948,490)
|
| Tax expense |
|
|
0
|
0
|
| NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS |
|
|
(1,884,406)
|
(1,948,490)
|
| Fair value loss on investments in equity securities |
|
|
|
119,499
|
| Gain on disposal of investments in equity securities |
|
|
|
$ (42,376)
|
| Share-based compensation |
|
|
$ (799,998)
|
|